Patrick Daly

Articles by Patrick Daly

Patrick DalyNon-Small Cell Lung Cancer | October 16, 2023
Investigators evaluated a non-platinum chemotherapy regimen of S-1 plus docetaxel or gemcitabine in patients with ...
Patrick DalyNon-Small Cell Lung Cancer | October 16, 2023
Authors of a study, published in Lung Cancer, evaluated real-world data from US patients with metastatic non-squamous ...
Patrick DalyNon-Small Cell Lung Cancer | September 21, 2023
According to a study published in The New England Journal of Medicine, recent improvements in the detection of ...
Patrick DalyLung Cancer | September 21, 2023
Early menopause, shortened reproductive span, and other reproductive factors were linked to risk of lung cancer in women.
Patrick DalyNon-Small Cell Lung Cancer | September 21, 2023
JK5G postbiotics may improve gut microbiota, QOL, and appetite in patients with advanced NSCLC on PD-1 inhibitor therapy.
Patrick DalyNon-Small Cell Lung Cancer | September 21, 2023
In a recent study, published in Thoracic Cancer, researchers evaluated the safety and efficacy of osimertinib plus ...
Patrick DalyNon-Small Cell Lung Cancer | September 21, 2023
In a recent meta-analysis, published in Cancer, researchers evaluated neoadjuvant immunotherapy in patients with ...
Patrick DalyNon-Small Cell Lung Cancer | September 21, 2023
In the recent GAP BRAIN trial, researchers evaluated gefitinib, a tyrosine kinase inhibitor (TKI), with or without ...
Patrick DalyNon-Small Cell Lung Cancer | September 21, 2023
In the recently completed CheckMate 817 trial, researchers evaluated flat-dose nivolumab plus weight-adjusted ipilimumab ...
Patrick DalyLung Cancer | September 21, 2023
In JAMA Network Open, researchers evaluated SGM-101, a carcinoembryonic antigen-related cell adhesion molecule type 5 ...
Patrick DalyNon-Small Cell Lung Cancer | September 21, 2023
In a recent study, researchers evaluated the safety and efficacy of first-line rezivertinib (BPI-7711), a ...
Patrick DalySmall Cell Lung Cancer | September 21, 2023
Researchers investigated the effects of adding programmed cell death 1 (PD-1) inhibition to chemotherapy in patients ...
Patrick DalyLung Cancer | September 21, 2023
In a recent meta-analysis, Xin Tao and colleagues examined the capability of omega-3 polyunsaturated fatty acids (PUFAs) ...
Patrick DalyNon-Small Cell Lung Cancer | September 21, 2023
According to a report in Thoracic Cancer, circular RNA ataxin 7 (circATXN7) has been shown to have a "promoting ...
Patrick DalySmall Cell Lung Cancer | September 21, 2023
Researchers set out to characterize survival outcomes in patients with small cell lung cancer (SCLC) treated with ...
Patrick DalySmall Cell Lung Cancer | September 21, 2023
Immune checkpoint inhibitors (ICIs) are approved for treatment of small cell lung cancer (SCLC). However, according to ...
Patrick DalySmall Cell Lung Cancer | September 21, 2023
In part one of the phase II/III RESILIENT trial, led by Luis Paz-Ares, researchers evaluated outcomes of second-line ...
Patrick DalySmall Cell Lung Cancer | September 21, 2023
In a phase II trial, published in Thoracic Cancer, researchers evaluated the impact of apatinib as a maintenance ...
Patrick DalySmall Cell Lung Cancer | September 21, 2023
Patients with extensive-stage small cell lung cancer (ES-SCLC) continue to face poor survival outcomes. Consolidative ...
Patrick DalyLung Cancer | September 21, 2023
In an article, published in Frontiers in Neuroscience, researchers sought to uncover associations between heart rate ...